Explore
Upload

DocSlides is a free service to upload presentations and documents.

Upload Now

Search Results for 'Virologic'

Virologic published presentations and documents on DocSlides.

Switch to ATV/

Switch to ATV/

  • cheryl-pisano
  • 16 Slides

r. + RAL. HARNESS Study. ATV/. r. 300/100 mg ....

Treatment with the second-generation HCV protease inhibitor

Treatment with the second-generation HCV protease inhibitor

  • conchita-marotz
  • 20 Slides

Results from SILEN-C1 in HCV genotype-1 treatment...

Switch to DTG/ABC/3TC

Switch to DTG/ABC/3TC

  • karlyn-bohler
  • 10 Slides

STRIIVING . Study. Design. Endpoints. Primary: pr...

Comparison of NNRTI vs PI/r

Comparison of NNRTI vs PI/r

  • alexa-scheidler
  • 14 Slides

EFV vs LPV/r vs EFV + LPV/r . A5142. Mexican. . ...

Maximizing Virologic Suppression: a win for the individual, a win for the community

Maximizing Virologic Suppression: a win for the individual, a win for the community

  • natalia-silvester
  • 0 Slides

May 21, . 2013. . For Audio: Dial-in#: 866.394.2...

Dual ART: Entering a New Paradigm

Dual ART: Entering a New Paradigm

  • pamella-moone
  • 0 Slides

Moderator. François Raffi, MD, PhD. Professor of...

Newborn born TO hiv ( )

Newborn born TO hiv ( )

  • test
  • 0 Slides

mother. ID weekly conferences. Gouri Scheurmann ....

Comprehensive Guideline Summary

Comprehensive Guideline Summary

  • aaron
  • 0 Slides

Guidelines for the Use of Antiretroviral Agents. ...

Superior Efficacy of Dolutegravir (DTG) Plus

Superior Efficacy of Dolutegravir (DTG) Plus

  • celsa-spraggs
  • 0 Slides

2 Nucleoside Reverse Transcriptase Inhibitors (NR...

Influenza & Other

Influenza & Other

  • giovanna-bartolotta
  • 0 Slides

Respiratory Viruses Update. 2013-2014. Pete Shult...

Modifying Therapy in the Treatment-experienced Patient:

Modifying Therapy in the Treatment-experienced Patient:

  • yoshiko-marsland
  • 0 Slides

When should it be done?. Professor of Medicine. U...

Prevention of new infections by

Prevention of new infections by

  • giovanna-bartolotta
  • 0 Slides

reducing Viral transmission –VL monitoring in A...

Comparison of PI vs PI ATV vs ATV/r BMS 089

Comparison of PI vs PI ATV vs ATV/r BMS 089

  • phoebe-click
  • 0 Slides

LPV/r mono vs LPV/r ZDV/3TC MONARK. LPV/r QD v...

Dolutegravir monotherapy

Dolutegravir monotherapy

  • alexa-scheidler
  • 15 Slides

Dolutegravir monotherapy vs. dolutegravir/ abac...

1 Queen Mary University, London, United Kingdom;

1 Queen Mary University, London, United Kingdom;

  • trish-goza
  • 15 Slides

1 Queen Mary University, London, United Kingdom; ...

1 University of Nebraska Medical Center, Omaha, NE, United States;

1 University of Nebraska Medical Center, Omaha, NE, United States;

  • min-jolicoeur
  • 16 Slides

1 University of Nebraska Medical Center, Omaha, N...

CROI Update: Best of Boston

CROI Update: Best of Boston

  • triclin
  • 54 Slides

p. resented by. NCATEC. March . 18, . 2014. David ...

Fixed Dose Combination Anti-retroviral Drugs

Fixed Dose Combination Anti-retroviral Drugs

  • dudeja
  • 9 Slides

had . Comparable Immunological. , . Virological. ...

Joel E. Gallant, MD, MPH

Joel E. Gallant, MD, MPH

  • mastervisa
  • 11 Slides

Medical Director, Specialty . Services. Southwest ...

Dolutegravir plus Rilpivirine as Maintenance Dual Therapy

Dolutegravir plus Rilpivirine as Maintenance Dual Therapy

  • quinn
  • 13 Slides

SWORD-1 . and SWORD-. 2. Dolutegravir plus Rilpivi...

Dolutegravir-Lamivudine (

Dolutegravir-Lamivudine (

  • audrey
  • 43 Slides

Dovato. ). Last Updated: November 28, 2022. Prepar...

Darunavir + RTV versus

Darunavir + RTV versus

  • willow
  • 9 Slides

Lopinavir. -RTV in Treatment Experienced. TITAN Tr...

Faculty W. David Hardy, MD, AAHIVS

Faculty W. David Hardy, MD, AAHIVS

  • christina
  • 112 Slides

Scientific and Medical Consultant. Adjunct Clinica...

Switching Antiretroviral Therapy (ART) in Your African American Patients: When and How

Switching Antiretroviral Therapy (ART) in Your African American Patients: When and How

  • taylor
  • 29 Slides

Supported by an educational grant from Gilead Scie...

Thinking of Now and Tomorrow: Emerging Treatment Paradigms

Thinking of Now and Tomorrow: Emerging Treatment Paradigms

  • deena
  • 32 Slides

Pedro Cahn. Disclosures. Advisory. . boards. : Me...

Switch to RAL-containing regimen

Switch to RAL-containing regimen

  • josephine
  • 25 Slides

Canadian Study. CHEER. Montreal Study. EASIER. SWI...

Virologic and Immunologic Monitoring in HIV Care

Virologic and Immunologic Monitoring in HIV Care

  • sylvia
  • 12 Slides

and. HIV Resistance Assays. www.hivguidelines.org....

Dolutegravir ( Tivicay )

Dolutegravir ( Tivicay )

  • brown
  • 100 Slides

Prepared by:. Brian R. Wood, MD. David H. Spach, M...

Emergence of resistance in

Emergence of resistance in

  • emma
  • 1 Slides

HIV-1 Integrase . following dolutegravir (DTG) tre...

In der vorliegenden Präsentation können Informationen zu Arzneimitteln von Janssen enthalten sein

In der vorliegenden Präsentation können Informationen zu Arzneimitteln von Janssen enthalten sein

  • lam
  • 21 Slides

Diese Präsentation dient ausschließlich der wiss...

Lower than Expected HIV Incidence among Men and Women at Elevated

Lower than Expected HIV Incidence among Men and Women at Elevated

  • harmony
  • 32 Slides

HIV Risk in a Population-based . PrEP. Study in R...

Switch to DRV/r + 3TC DUAL Study

Switch to DRV/r + 3TC DUAL Study

  • jireh
  • 9 Slides

DRV/r 800/100 + 3TC 300 QD. N = 126. N = 123. DRV/...

NRTI-sparing SPARTAN PROGRESS

NRTI-sparing SPARTAN PROGRESS

  • shepard237
  • 5 Slides

RADAR. NEAT001/ANRS 14. 3 . A4001078. VEMAN. MODER...

JM Llibre , 1 C-C Hung,

JM Llibre , 1 C-C Hung,

  • mohammad106
  • 16 Slides

2. C Brinson,. 3. F Castelli,. 4. P-M Girard,. ...

Raltegravir + Darunavir/r versus TDF-FTC + Darunavir/r RADAR Trial

Raltegravir + Darunavir/r versus TDF-FTC + Darunavir/r RADAR Trial

  • keanu817
  • 7 Slides

RADAR Trial. Raltegravir. + Darunavir/r versus TD...

Copyright © 2024 DocSlides. All Rights Reserved